Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$2,648.23 /

+6.06 (+0.23%)

14:35
06/18/20
06/18
14:35
06/18/20
14:35

TwitchCon San Diego canceled amid COVID-19 concerns

TwitchCon, a biannual convention for Amazon's live streaming platform Twitch, said via Twitter: "In March, we made the incredibly difficult decision to cancel TwitchCon Amsterdam. Over the past few months, we have continued to closely monitor the COVID-19 pandemic with TwitchCon San Diego weighing on our minds. Due to restrictions on large gatherings and ongoing concerns for the healthy and safety of our community, the Twitch team, and the local San Diego community, we have decided to cancel TwitchCon San Diego this fall. We are gutted that we won't be able to see all of you in person to connect and show you what we've been creating for you over the past year. While we can't gather in person, we're exploring ways that we could join forces in an alternate dimension later this year. We'll keep you posted." The event had been previously scheduled for September 25-27. Reference Link

  • 18

    Jun

  • 14

    Sep

AMZN Amazon.com
$2,648.23 /

+6.06 (+0.23%)

06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Stifel
Oracle price target raised to $48 from $44 at Stifel
06/17/20 Jefferies
Oracle results reflective of continued share losses, says Jefferies
06/16/20 Jefferies
Jefferies continues to prefer Microsoft to Oracle in large-cap software

TODAY'S FREE FLY STORIES

Hot Stocks
Orchard Therapeutics expects cash, investments to fund operations into 2022 » 07:03
08/06/20
08/06
07:03
08/06/20
07:03
ORTX

Orchard Therapeutics

$4.87 /

-0.14 (-2.79%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

05/22/20 JPMorgan
Orchard Therapeutics price target lowered to $17 from $26 at JPMorgan
09/17/19
Fly Intel: Top five analyst initiations
09/17/19
Guggenheim bullish on Orchard Therapeutics, initiates with a Buy
09/17/19 Guggenheim
Orchard Therapeutics initiated with a Buy at Guggenheim
ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

Earnings
Orchard Therapeutics reports Q2 EPS (48c), consensus (42c) » 07:02
08/06/20
08/06
07:02
08/06/20
07:02
ORTX

Orchard Therapeutics

$4.87 /

-0.14 (-2.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

05/22/20 JPMorgan
Orchard Therapeutics price target lowered to $17 from $26 at JPMorgan
09/17/19
Fly Intel: Top five analyst initiations
09/17/19
Guggenheim bullish on Orchard Therapeutics, initiates with a Buy
09/17/19 Guggenheim
Orchard Therapeutics initiated with a Buy at Guggenheim
ORTX Orchard Therapeutics
$4.87 /

-0.14 (-2.79%)

Recommendations
Regeneron price target raised to $675 from $615 at Barclays » 07:02
08/06/20
08/06
07:02
08/06/20
07:02
REGN

Regeneron

$624.53 /

-22.56 (-3.49%)

Barclays analyst Carter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$624.53 /

-22.56 (-3.49%)

REGN Regeneron
$624.53 /

-22.56 (-3.49%)

08/05/20 Piper Sandler
Regeneron price target raised to $675 from $630 at Piper Sandler
08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
REGN Regeneron
$624.53 /

-22.56 (-3.49%)

  • 27
    May
REGN Regeneron
$624.53 /

-22.56 (-3.49%)

REGN Regeneron
$624.53 /

-22.56 (-3.49%)

REGN Regeneron
$624.53 /

-22.56 (-3.49%)

Hot Stocks
Bausch Health to spin off eye health business into publicly traded company  07:02
08/06/20
08/06
07:02
08/06/20
07:02
BHC

Bausch Health

$19.45 /

+0.46 (+2.42%)

 
ShowHide Related Items >><<
BHC Bausch Health
$19.45 /

+0.46 (+2.42%)

BHC Bausch Health
$19.45 /

+0.46 (+2.42%)

06/17/20 H.C. Wainwright
Bausch Health price target raised to $64 from $50 at H.C. Wainwright
06/03/20 Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
BHC Bausch Health
$19.45 /

+0.46 (+2.42%)

BHC Bausch Health
$19.45 /

+0.46 (+2.42%)

BHC Bausch Health
$19.45 /

+0.46 (+2.42%)

Earnings
Bristol-Myers reports Q2 non-GAAP EPS $1.63, consensus $1.48 » 07:02
08/06/20
08/06
07:02
08/06/20
07:02
BMY

Bristol-Myers

$59.69 /

+0.26 (+0.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
07/22/20 Morgan Stanley
Morgan Stanley sees 'encouraging news' coming in near-term for Bristol-Myers
BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

Hot Stocks
Quanta Services announces up to $500M share repurchase program » 07:01
08/06/20
08/06
07:01
08/06/20
07:01
PWR

Quanta Services

$42.88 /

+1.37 (+3.30%)

Quanta Services announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

07/17/20 B. Riley FBR
Quanta Services price target raised to $47 from $42 at B. Riley FBR
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
06/23/20 Stifel
Quanta Services price target raised to $50 from $46 at Stifel
05/28/20 Northland
Quanta Services initiated with an Outperform at Northland
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

Recommendations
Synaptics price target raised to $90 from $70 at BMO Capital » 07:01
08/06/20
08/06
07:01
08/06/20
07:01
SYNA

Synaptics

$82.86 /

+0.55 (+0.67%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNA Synaptics
$82.86 /

+0.55 (+0.67%)

SYNA Synaptics
$82.86 /

+0.55 (+0.67%)

06:46 Today Mizuho
Synaptics price target raised to $90 from $77 at Mizuho
01:30 Today KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
07/21/20 Susquehanna
DisplayLink changes outlook for Synaptics, Susquehanna ups to Positive
07/21/20 Susquehanna
Synaptics upgraded to Positive from Neutral at Susquehanna
SYNA Synaptics
$82.86 /

+0.55 (+0.67%)

SYNA Synaptics
$82.86 /

+0.55 (+0.67%)

Hot Stocks
Party City expects to close 21 stores and open 4 » 07:00
08/06/20
08/06
07:00
08/06/20
07:00
PRTY

Party City

$1.82 /

+0.06 (+3.41%)

During the remainder of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

03/13/20 Stephens
Party City downgraded to Equal Weight from Overweight at Stephens
01/03/20 Morgan Stanley
Party City price target lowered to $3 from $5 at Morgan Stanley
11/08/19 Goldman Sachs
Party City downgraded to Neutral from Buy at Goldman Sachs
PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

Upgrade
Tivity Health upgraded to Buy from Hold at Craig-Hallum » 07:00
08/06/20
08/06
07:00
08/06/20
07:00
TVTY

Tivity Health

$13.60 /

-0.05 (-0.37%)

Craig-Hallum analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

06/12/20 Guggenheim
Tivity Health initiated with a Neutral at Guggenheim
05/07/20 Barrington
Tivity Health price target lowered to $15 from $24 at Barrington
03/16/20 Craig-Hallum
Tivity Health price target lowered to $4 from $18 at Craig-Hallum
02/20/20 Barrington
'Extremely disappointed' Barrington cuts Tivity Health target to $24
TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

Earnings
Quanta Services sees FY20 adj. EPS $3.18-$3.48, consensus $3.17 » 07:00
08/06/20
08/06
07:00
08/06/20
07:00
PWR

Quanta Services

$42.88 /

+1.37 (+3.30%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

07/17/20 B. Riley FBR
Quanta Services price target raised to $47 from $42 at B. Riley FBR
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
06/23/20 Stifel
Quanta Services price target raised to $50 from $46 at Stifel
05/28/20 Northland
Quanta Services initiated with an Outperform at Northland
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

Earnings
Cardinal Health sees FY21 EPS $5.25-$5.65, consensus $5.54 » 07:00
08/06/20
08/06
07:00
08/06/20
07:00
CAH

Cardinal Health

$57.61 /

-0.22 (-0.38%)

Cardinal Health said in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

07/20/20
Fly Intel: Top five analyst upgrades
07/20/20 Guggenheim
Guggenheim upgrades Cardinal Health to Buy as healthcare environment normalizes
07/20/20 Guggenheim
Cardinal Health upgraded to Buy from Neutral at Guggenheim
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

General news
European stock markets headed south, » 07:00
08/06/20
08/06
07:00
08/06/20
07:00

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays » 06:59
08/06/20
08/06
06:59
08/06/20
06:59
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

Barclays analyst Gena…

Barclays analyst Gena Wang raised the firm's price target on Moderna (MRNA) to $84 from $68 and keeps an Overweight rating on the shares. The stock closed Wednesday down $2.66 to $75.50. The company's Q2 update highlighted pipeline progress including mRNA-1273 Phase 3 trial enrollment for COVID-19 completion by the end of September, Wang tells investors in a research note. Approximately $400M customer deposits were received as of July 31 for commercial supply of mRNA-1273, and discussions with countries are ongoing, the analyst points out. While Novavax's (NVAX) vaccine data were encouraging, the high neutralizing titers in the mRNA-1273 Phase 1 trial continue to support mRNA-1273's "best-in-class potential," Wang contends.

ShowHide Related Items >><<
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

06:38 Today H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

Earnings
Party City reports Q2 adjusted EPS (66c), consensus (56c) » 06:59
08/06/20
08/06
06:59
08/06/20
06:59
PRTY

Party City

$1.82 /

+0.06 (+3.41%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

03/13/20 Stephens
Party City downgraded to Equal Weight from Overweight at Stephens
01/03/20 Morgan Stanley
Party City price target lowered to $3 from $5 at Morgan Stanley
11/08/19 Goldman Sachs
Party City downgraded to Neutral from Buy at Goldman Sachs
PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

PRTY Party City
$1.82 /

+0.06 (+3.41%)

Hot Stocks
The Buckle reports July net sales up 3.8% to $70M » 06:58
08/06/20
08/06
06:58
08/06/20
06:58
BKE

The Buckle

$16.75 /

-0.47 (-2.73%)

The Buckle announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKE The Buckle
$16.75 /

-0.47 (-2.73%)

BKE The Buckle
$16.75 /

-0.47 (-2.73%)

Recommendations
Roku price target raised to $185 after 'stellar quarter' at Benchmark » 06:58
08/06/20
08/06
06:58
08/06/20
06:58
ROKU

Roku

$165.76 /

-0.57 (-0.34%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$165.76 /

-0.57 (-0.34%)

ROKU Roku
$165.76 /

-0.57 (-0.34%)

05:46 Today Pivotal Research
Roku price target raised to $65 from $60 at Pivotal Research
08/04/20 Rosenblatt
Roku price target raised to $190 from $145 at Rosenblatt
08/03/20 Loop Capital
Roku price target raised to $120 from $90 at Loop Capital
07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
ROKU Roku
$165.76 /

-0.57 (-0.34%)

  • 17
    Mar
ROKU Roku
$165.76 /

-0.57 (-0.34%)

ROKU Roku
$165.76 /

-0.57 (-0.34%)

ROKU Roku
$165.76 /

-0.57 (-0.34%)

Earnings
Cardinal Health reports Q4 EPS $1.04, consensus 92c » 06:58
08/06/20
08/06
06:58
08/06/20
06:58
CAH

Cardinal Health

$57.61 /

-0.22 (-0.38%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

07/20/20
Fly Intel: Top five analyst upgrades
07/20/20 Guggenheim
Guggenheim upgrades Cardinal Health to Buy as healthcare environment normalizes
07/20/20 Guggenheim
Cardinal Health upgraded to Buy from Neutral at Guggenheim
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

CAH Cardinal Health
$57.61 /

-0.22 (-0.38%)

Earnings
Quanta Services reports Q2 adj. EPS 74c, consensus 48c » 06:58
08/06/20
08/06
06:58
08/06/20
06:58
PWR

Quanta Services

$42.88 /

+1.37 (+3.30%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

07/17/20 B. Riley FBR
Quanta Services price target raised to $47 from $42 at B. Riley FBR
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
06/23/20 Stifel
Quanta Services price target raised to $50 from $46 at Stifel
05/28/20 Northland
Quanta Services initiated with an Outperform at Northland
PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

PWR Quanta Services
$42.88 /

+1.37 (+3.30%)

Recommendations
Verisk Analytics price target raised to $181 from $156 at BMO Capital » 06:57
08/06/20
08/06
06:57
08/06/20
06:57
VRSK

Verisk Analytics

$187.02 /

-0.11 (-0.06%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$187.02 /

-0.11 (-0.06%)

VRSK Verisk Analytics
$187.02 /

-0.11 (-0.06%)

05/07/20 Wells Fargo
Verisk Analytics price target raised to $190 from $175 at Wells Fargo
04/01/20 Baird
Verisk Analytics a good defensive long term core holding, says Baird
03/30/20 RBC Capital
Verisk Analytics initiated with a Sector Perform at RBC Capital
01/22/20 Baird
Verisk Analytics price target raised to $184 from $165 at Baird
VRSK Verisk Analytics
$187.02 /

-0.11 (-0.06%)

Hot Stocks
Targa Resources sees 2020 adjusted EBITDA $1.5B-$1.63B  06:57
08/06/20
08/06
06:57
08/06/20
06:57
TRGP

Targa Resources

$20.15 /

+0.41 (+2.08%)

 
ShowHide Related Items >><<
TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

07/27/20 Seaport Global
Targa Resources downgraded to Neutral from Buy at Seaport Global
06/04/20 Barclays
Barclays upgrades Targa Resources to Overweight on favorable risk/reward
06/04/20 Barclays
Targa Resources upgraded to Overweight from Equal Weight at Barclays
06/03/20 JPMorgan
Targa Resources price target raised to $24 from $19 at JPMorgan
TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

Earnings
Targa Resources reports Q2 revenue $1.52B, consensus $1.62B » 06:56
08/06/20
08/06
06:56
08/06/20
06:56
TRGP

Targa Resources

$20.15 /

+0.41 (+2.08%)

Reports Q2 net income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

07/27/20 Seaport Global
Targa Resources downgraded to Neutral from Buy at Seaport Global
06/04/20 Barclays
Barclays upgrades Targa Resources to Overweight on favorable risk/reward
06/04/20 Barclays
Targa Resources upgraded to Overweight from Equal Weight at Barclays
06/03/20 JPMorgan
Targa Resources price target raised to $24 from $19 at JPMorgan
TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

TRGP Targa Resources
$20.15 /

+0.41 (+2.08%)

Hot Stocks
Zedge promotes Jonathan Reich to CEO, Yi Tsai to CFO » 06:56
08/06/20
08/06
06:56
08/06/20
06:56
ZDGE

Zedge, Inc.

$1.49 /

-0.01 (-0.67%)

Zedge announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Adient sees Q4 revenue $3.3B-$3.5B, consensus $3.31B » 06:56
08/06/20
08/06
06:56
08/06/20
06:56
ADNT

Adient

$18.30 /

+0.655 (+3.71%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$18.30 /

+0.655 (+3.71%)

ADNT Adient
$18.30 /

+0.655 (+3.71%)

06/19/20 JPMorgan
Adient price target raised to $13 from $11 at JPMorgan
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 KeyBanc
Adient upgraded to Overweight from Sector Weight at KeyBanc
05/06/20 RBC Capital
Adient upgraded to Outperform from Sector Perform at RBC Capital
ADNT Adient
$18.30 /

+0.655 (+3.71%)

ADNT Adient
$18.30 /

+0.655 (+3.71%)

Earnings
Kontoor Brands says 2H20 revenue should improve y/y » 06:55
08/06/20
08/06
06:55
08/06/20
06:55
KTB

Kontoor Brands

$21.21 /

+1.34 (+6.74%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTB Kontoor Brands
$21.21 /

+1.34 (+6.74%)

KTB Kontoor Brands
$21.21 /

+1.34 (+6.74%)

07/27/20 Goldman Sachs
Kontoor Brands upgraded to Buy from Sell at Goldman Sachs
07/22/20 UBS
Kontoor Brands initiated with a Neutral at UBS
06/16/20 Exane BNP Paribas
Kontoor Brands initiated with an Underperform at Exane BNP Paribas
06/11/20 Piper Sandler
Kontoor Brands price target raised to $29 from $20 at Piper Sandler
KTB Kontoor Brands
$21.21 /

+1.34 (+6.74%)

KTB Kontoor Brands
$21.21 /

+1.34 (+6.74%)

Upgrade
Barclays upgrades Wayfair with bear thesis turned 'on its head' post Q2 » 06:55
08/06/20
08/06
06:55
08/06/20
06:55
W

Wayfair

$300.89 /

+10.09 (+3.47%)

Barclays analyst Adrienne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
W Wayfair
$300.89 /

+10.09 (+3.47%)

W Wayfair
$300.89 /

+10.09 (+3.47%)

06:42 Today DA Davidson
Wayfair upgraded to Neutral from Underperform at DA Davidson
06:12 Today Piper Sandler
Wayfair price target raised to $370 from $275 at Piper Sandler
04:47 Today Barclays
Wayfair upgraded to Equal Weight from Underweight at Barclays
08/05/20 Baird
Wayfair price target raised to $315 from $225 at Baird
W Wayfair
$300.89 /

+10.09 (+3.47%)

W Wayfair
$300.89 /

+10.09 (+3.47%)

W Wayfair
$300.89 /

+10.09 (+3.47%)

W Wayfair
$300.89 /

+10.09 (+3.47%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.